Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -160.81% is 98% below its 5-year average of -81.11%, near the low end of its 5-year range (-172.87%–-20.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.02% below its 12-month average of -139.81%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -160.81%.
RETURN ON INVESTED CAPITAL (ROIC)
-160.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-139.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-104.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-81.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-96.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.02%
CURRENT VS 3Y AVG
-53.99%
CURRENT VS 5Y AVG
-98.26%
CURRENT VS 10Y AVG
-66.88%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-351.15%
vs the sector median at left
Pulmatrix, Inc.
Market Cap
$5.22M
Return on Invested Capital (ROIC)
-160.81%
TTM Avg
-139.81%
3Y Avg
-104.43%
5Y Avg
-81.11%
Market Cap
$5.23M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-654.50%
3Y Avg
-599.09%
5Y Avg
-420.09%
Market Cap
$5.17M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-67.32%
3Y Avg
-73.33%
5Y Avg
-73.33%
Market Cap
$5.14M
Return on Invested Capital (ROIC)
-175.26%
TTM Avg
-258.55%
3Y Avg
-208.94%
5Y Avg
-173.09%
Market Cap
$5.28M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$5.31M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-259.96%
3Y Avg
-220.56%
5Y Avg
-170.22%
Market Cap
$5.06M
Return on Invested Capital (ROIC)
-225.12%
TTM Avg
-13.17%
3Y Avg
-9.09%
5Y Avg
-9.09%
Market Cap
$5.33M
Return on Invested Capital (ROIC)
-161.69%
TTM Avg
-192.94%
3Y Avg
-175.58%
5Y Avg
-149.58%
Market Cap
$5.17M
Return on Invested Capital (ROIC)
-35.07%
TTM Avg
-9.54%
3Y Avg
2.54%
5Y Avg
2.54%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmatrix, Inc. (PULM) | $5.22M | -160.81% | -139.81% | -104.43% | -81.11% |
| Alzamend Neuro Inc (ALZN)vs › | $5.23M | -156.69% | -654.50% | -599.09% | -420.09% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.17M | N/A | -67.32% | -73.33% | -73.33% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.14M | -175.26% | -258.55% | -208.94% | -173.09% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.28M | -27.41% | -21.46% | -17.98% | -12.44% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.31M | -179.58% | -259.96% | -220.56% | -170.22% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.06M | -225.12% | -13.17% | -9.09% | -9.09% |
| Soligenix, Inc. (SNGX)vs › | $5.33M | -161.69% | -192.94% | -175.58% | -149.58% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.17M | -35.07% | -9.54% | 2.54% | 2.54% |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.02M | -43.50% | -54.16% | -50.91% | -58.12% |
ROIC
-160.8%
ROE
-156.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -160.81% |
| 2026-03-31 | -128.49% |
| 2025-12-31 | -135.67% |
| 2025-09-30 | -131.27% |
| 2025-06-30 | -142.83% |
| 2025-03-31 | -172.87% |
| 2024-12-31 | -108.31% |
| 2024-09-30 | -91.90% |
| 2024-06-30 | -85.03% |
| 2024-03-31 | -34.53% |
| 2023-12-31 | -49.05% |
| 2023-09-30 | -52.07% |
| 2023-06-30 | -64.76% |
| 2023-03-31 | -59.27% |
| 2022-12-31 | -52.73% |
| 2022-09-30 | -46.52% |
| 2022-06-30 | -49.67% |
| 2022-03-31 | -43.01% |
| 2021-12-31 | -37.09% |
| 2021-09-30 | -37.14% |
| 2021-06-30 | -20.31% |
| 2021-03-31 | -14.67% |
| 2020-12-31 | -32.97% |
| 2020-09-30 | -34.89% |
| 2020-06-30 | -67.03% |
| 2020-03-31 | -152.06% |
| 2019-12-31 | -109.49% |
| 2019-09-30 | -98.66% |
| 2019-06-30 | -90.81% |
| 2019-03-31 | -198.54% |
| 2018-12-31 | -172.24% |
| 2018-09-30 | -162.23% |
| 2018-06-30 | -118.91% |
| 2018-03-31 | -191.76% |
| 2017-12-31 | -130.80% |
| 2017-09-30 | -122.69% |
| 2017-06-30 | -94.22% |
| 2017-03-31 | -107.65% |
| 2016-12-31 | -170.33% |
| 2016-09-30 | -90.86% |
| 2016-06-30 | -86.73% |
| 2016-03-31 | -67.87% |
| 2015-12-31 | -54.43% |
| 2015-09-30 | -44.63% |
| 2015-06-30 | -37.32% |
| 2015-03-31 | -17.82% |
| 2014-12-31 | -17.80% |
| 2014-09-30 | -63.88% |
| 2014-06-30 | -46.21% |
| 2014-03-31 | -31.03% |
| 2013-03-31 | -1112.77% |
